1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About CVRx Inc



Pre-market Movers: IMCC, CVRX, TGTX, ROOT, PLTN.
May 01, 2024 13:24pm

WOONSOCKET (dpa-AFX) - The following are some of the stocks making big moves in Wednesday''s pre-market trading (as of 09.00 A.M. ET).In the Green IM Cannabis Corp. (IMCC) is up over 36% at $0.86. …

Source:Finanz Nachrichten
Why Is Cemtrex (CETX) Stock Down 40% Today?
May 01, 2024 12:56pm

Cemtrex (NASDAQ: CETX ) stock is falling on Wednesday after the company launched a public offering of its shares. This public offering has the company selling 5,056,179 shares of CETX stock at an assumed price of $1.78 per share. This price may be different depending on negotiations with underwriters. Each unit also comes with one Series A Warrant and one Series B Warrant. These warrants can each be exercised for an additional share of CETX stock. The exercise price for the warrants matches the assumed price of shares in the public offering. They are exercisable immediately. The Series A ones expire in two and a half years and the Series B ones expire in five years. Underwriters also have a 45-day option to acquire another 758,427 shares in the offering for the offering price. Aegis Capital Corp is the underwriter for this offering. CETX Stock Standstill Agreement Other news from Cemtrex includes a standstill agreement with Streeterville Capital, LLC . This has Streeterville Capital, LLC agreeing not to redeem two of its secured notes for one year.

Why Is CVRx (CVRX) Stock Down 32% Today?
May 01, 2024 12:39pm

CVRx (NASDAQ: CVRX ) stock is falling hard on Wednesday after posting results from its earnings report for the first quarter of 2024 . The bad news for investors in CVRX stock starts with its earnings per share of 0$1.04. That’s much worse than the -54 cents per share Wall Street was expecting. It’s also wider than the -55 cents per share from the same period of the year prior. Adding to this is CVRx’s revenue of $10.77 million. That’s another miss next to analysts’ estimate of $11.37 million for the quarter. However, it is up 35% year-over-year from $7.98 million. CVRx president and CEO Kevin Hykes said the following about the earnings results. “We had a solid first quarter, which was offset by some commercial execution challenges in our U.S. Heart Failure business during our recent management transition in February. We are taking steps to address these challenges, including a change in sales leadership, which we are announcing today.” CVRX Stock Falls on Weak Outlook CVRx’s guidance for the second quarter of 2024 has it expecting revenue to range from $11.3 million to $12.3 million.

CYCC, CETX and NRXP among pre-market losers
May 01, 2024 12:34pm

Read about the latest losers in the financial markets, including Cemtrex, CVRx, NRX Pharmaceuticals, and more, and understand the factors behind their…

Source:Seeking Alpha
Starbucks Reports Downbeat Earnings, Joins Skyworks Solutions, Super Micro Computer And Other Big Stocks Moving Lower In Wednesday''s Pre-Market Session
May 01, 2024 09:57am

U.S. stock futures were lower this morning, with the Nasdaq futures falling over 100 points on Wednesday. Shares of Starbucks Corporation (NASDAQ: SBUX ) fell sharply in today''s pre-market trading following weaker-than-expected second-quarter earnings . Starbucks said second-quarter revenue decreased 2% year-over-year to $8.6 billion, which missed the consensus estimate of $9.129 billion, according to Benzinga Pro. The company reported quarterly earnings of 68 cents per share, which missed analyst estimates of 79 cents per share. Starbucks shares dipped 12.1% to $77.79 in pre-market trading. Here are some big stocks recording losses in today''s pre-market trading session. CVRx Inc (NASDAQ: Full story available on

CVRx Inc (CVRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Setting ...
May 01, 2024 07:37am

CVRx Inc (CVRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Setting New Paths

Q1 2024 CVRx Inc Earnings Call Transcript
May 01, 2024 05:11am

Q1 2024 CVRx Inc Earnings Call Transcript

CVRx, Inc. (CVRX) Q1 2024 Earnings Call Transcript
May 01, 2024 02:38am

CVRx, Inc. (NASDAQ:NASDAQ:CVRX) Q1 2024 Earnings Conference Call April 30, 2024 5:00 PM ETCompany ParticipantsMike Vallie - IRKevin Hykes - President and…

Source:Seeking Alpha
CVRX Stock Earnings: CVRx Misses EPS, Misses Revenue for Q1 2024
May 01, 2024 00:56am

CVRx (NASDAQ: CVRX ) just reported results for the first quarter of 2024. CVRx reported earnings per share of -$1.04. This was below the analyst estimate for EPS of -54 cents. The company reported revenue of $10.77 million. This was 5.61% worse than the analyst estimate for revenue of $11.41 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
Apr 16, 2024 20:30pm

MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases, today announced that it plans to release first quarter 2024 financial and operating results after Jetzt den vollständigen Artikel lesen